ArticleJournal of clinical immunology2021

The "Editors" Take to RAG: Promise of CRISPR/Cas9/rAAV6-Based Gene Therapy for RAG2 Deficiency.

Vivien Béziat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.